[Translation] A randomized, double-blind, multicenter, placebo-controlled, dose-finding phase II clinical study evaluating the safety and efficacy of WXFL10203614 tablets in the treatment of moderately to severely active rheumatoid arthritis (RA)
(1) 初步评价WXFL10203614片治疗中重度活动性类风湿关节炎(RA)的有效性和安全性;
(2) 探索WXFL10203614片治疗中重度活动性类风湿关节炎(RA)的最佳剂量。
[Translation] (1) Preliminary evaluation of the efficacy and safety of WXFL10203614 tablets in the treatment of moderately to severely active rheumatoid arthritis (RA);
(2) To explore the optimal dose of WXFL10203614 tablets for moderate to severe active rheumatoid arthritis (RA).